Straumann Holding AG N (QS51.F)
- Previous Close
118.00 - Open
117.90 - Bid 118.60 x --
- Ask 122.55 x --
- Day's Range
117.90 - 118.60 - 52 Week Range
77.80 - 122.20 - Volume
160 - Avg. Volume
12 - Market Cap (intraday)
19.247B - Beta (5Y Monthly) 1.33
- PE Ratio (TTM)
38.63 - EPS (TTM)
3.07 - Earnings Date Aug 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 16, 2024
- 1y Target Est
--
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company also offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made of ceramics, metal or polymer; clear aligners and made of polymer; and biomaterials for tissue generation. In addition, it provides restorative solutions comprising abutments and related parts, as well as milling elements. Further, it provides digital equipment comprising scanners, milling machines, and 3D printers; software licenses; and training and other miscellaneous products. The company provides its products to general dentists, specialists, and dental technicians and laboratories through a network of distribution subsidiaries and partners, and third-party distributors. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
www.straumann.com11,342
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: QS51.F
View MorePerformance Overview: QS51.F
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: QS51.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: QS51.F
View MoreValuation Measures
Market Cap
19.00B
Enterprise Value
19.03B
Trailing P/E
38.68
Forward P/E
31.45
PEG Ratio (5yr expected)
1.95
Price/Sales (ttm)
7.07
Price/Book (mrq)
8.68
Enterprise Value/Revenue
7.15
Enterprise Value/EBITDA
24.66
Financial Highlights
Profitability and Income Statement
Profit Margin
15.51%
Return on Assets (ttm)
11.26%
Return on Equity (ttm)
23.67%
Revenue (ttm)
2.5B
Net Income Avi to Common (ttm)
457.63M
Diluted EPS (ttm)
3.07
Balance Sheet and Cash Flow
Total Cash (mrq)
383.07M
Total Debt/Equity (mrq)
20.28%
Levered Free Cash Flow (ttm)
343.46M